Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 495

1.

Neurovascular factors in wound healing in the foot skin of type 2 diabetic subjects.

Krishnan ST, Quattrini C, Jeziorska M, Malik RA, Rayman G.

Diabetes Care. 2007 Dec;30(12):3058-62.

PMID:
17898089
2.

Reduced vascular endothelial growth factor expression and intra-epidermal nerve fiber loss in human diabetic neuropathy.

Quattrini C, Jeziorska M, Boulton AJ, Malik RA.

Diabetes Care. 2008 Jan;31(1):140-5.

PMID:
17934147
3.

Neurovascular factors in wound healing in the foot skin of type 2 diabetic subjects: response to Krishnan et al.

Catrina SB, Brismar K.

Diabetes Care. 2008 Feb;31(2):e6; author reply e7. doi: 10.2337/dc07-1974. No abstract available.

PMID:
18227464
4.

Comparative roles of microvascular and nerve function in foot ulceration in type 2 diabetes.

Krishnan ST, Baker NR, Carrington AL, Rayman G.

Diabetes Care. 2004 Jun;27(6):1343-8.

PMID:
15161786
5.

The LDIflare: a novel test of C-fiber function demonstrates early neuropathy in type 2 diabetes.

Krishnan ST, Rayman G.

Diabetes Care. 2004 Dec;27(12):2930-5.

PMID:
15562209
6.

Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration.

Veves A, Akbari CM, Primavera J, Donaghue VM, Zacharoulis D, Chrzan JS, DeGirolami U, LoGerfo FW, Freeman R.

Diabetes. 1998 Mar;47(3):457-63.

PMID:
9519754
8.

Impaired skin microvascular reactivity in painful diabetic neuropathy.

Quattrini C, Harris ND, Malik RA, Tesfaye S.

Diabetes Care. 2007 Mar;30(3):655-9.

PMID:
17327336
9.

A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study.

Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG.

Diabetes Care. 1999 Jul;22(7):1036-42.

10.

Determinants and estimation of healing times in diabetic foot ulcers.

Zimny S, Schatz H, Pfohl M.

J Diabetes Complications. 2002 Sep-Oct;16(5):327-32.

PMID:
12200075
11.
12.

VEGF gene transfer for diabetic neuropathy.

Isner JM, Ropper A, Hirst K.

Hum Gene Ther. 2001 Aug 10;12(12):1593-4.

PMID:
11529248
13.

Early detection of microcirculatory impairment in diabetic patients with foot at risk.

Zimny S, Dessel F, Ehren M, Pfohl M, Schatz H.

Diabetes Care. 2001 Oct;24(10):1810-4.

PMID:
11574447
14.

Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy.

Hamdy O, Abou-Elenin K, LoGerfo FW, Horton ES, Veves A.

Diabetes Care. 2001 Feb;24(2):344-9.

PMID:
11213890
15.

Comparison of the microvascular response to transcutaneous electrical nerve stimulation and postocclusive ischemia in the diabetic foot.

Forst T, Pfützner A, Bauersachs R, Arin M, Bach B, Biehlmaier H, Küstner E, Beyer J.

J Diabetes Complications. 1997 Sep-Oct;11(5):291-7.

PMID:
9334912
16.

Endoneurial localisation of microvascular damage in human diabetic neuropathy.

Malik RA, Tesfaye S, Thompson SD, Veves A, Sharma AK, Boulton AJ, Ward JD.

Diabetologia. 1993 May;36(5):454-9.

PMID:
8314451
17.

Microvascular and C-fiber function in diabetic charcot neuroarthropathy and diabetic peripheral neuropathy.

Baker N, Green A, Krishnan S, Rayman G.

Diabetes Care. 2007 Dec;30(12):3077-9.

PMID:
17804679
19.

Impaired peripheral vasomotion in diabetes.

Stansberry KB, Shapiro SA, Hill MA, McNitt PM, Meyer MD, Vinik AI.

Diabetes Care. 1996 Jul;19(7):715-21.

PMID:
8799625
20.

Plantar tissue thickness is related to peak plantar pressure in the high-risk diabetic foot.

Abouaesha F, van Schie CH, Griffths GD, Young RJ, Boulton AJ.

Diabetes Care. 2001 Jul;24(7):1270-4.

PMID:
11423514
Items per page

Supplemental Content

Support Center